NCT00122603 - Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2005

Study Completion Date

August 31, 2007

Conditions

HIV Infections

Interventions

DRUG

Fosamprenavir

ATV (150mg: 2 pills per day) + RTV (100mg: 1 pill twice a day) + FPV (700mg: 1 pill twice a day)

DRUG

Saquinavir

ATV (150mg: 2 pills per day) + RTV (100mg: 1 pill per day) + SQV (500mg: 3 pills per day)

Trial Locations (1)

Service des Maladies infectieuses et tropicales Hopital Bichat Claude Bernard, Paris